CT Findings of COVID-19-associated Pulmonary Aspergillosis: a Systematic Review and Individual Patient Data Analysis
Overview
Authors
Affiliations
Purpose: Common CT abnormalities of pulmonary aspergillosis represent a cavity with air-meniscus sign, nodule, mass, and consolidation having an angio-invasive pattern. This study aims to conduct a systematic review and an individual patient-level image analysis of CT findings of COVID-19-associated pulmonary aspergillosis (CAPA).
Methods: A systematic literature search was conducted to identify studies reporting CT findings of CAPA as of January 7, 2021. We summarized study-level clinical and CT findings of CAPA and collected individual patient CT images by inviting corresponding authors. The CT findings were categorized into four groups: group 1, typical appearance of COVID-19; group 2, indeterminate appearance of COVID-19; group 3, atypical for COVID-19 without cavities; and group 4, atypical for COVID-19 with cavities. In group 2, cases had only minor discrepant findings including solid nodules, isolated airspace consolidation with negligible ground-glass opacities, centrilobular micronodules, bronchial abnormalities, and cavities.
Results: The literature search identified 89 patients from 25 studies, and we collected CT images from 35 CAPA patients (mean age 62.4 ± 14.6 years; 21 men): group 1, thirteen patients (37.1%); group 2, eight patients (22.9%); group 3, six patients (17.1%); and group 4, eight patients (22.9%). Eight of the 14 patients (57.1%) with an atypical appearance had bronchial abnormalities, whereas only one (7.1%) had an angio-invasive fungal pattern. In the study-level analysis, cavities were reported in 12 of 54 patients (22.2%).
Conclusion: CAPA can frequently manifest as COVID-19 pneumonia without common CT abnormalities of pulmonary aspergillosis. If abnormalities exist on CT images, CAPA may frequently accompany bronchial abnormalities.
Severe mold fungal infections in critically ill patients with COVID-19.
Koulenti D, Paramythiotou E, Almyroudi M, Karvouniaris M, Markou N, Paranos P Future Microbiol. 2024; 19(9):825-840.
PMID: 38700287 PMC: 11290760. DOI: 10.2217/fmb-2023-0261.
Iacovelli A, Oliva A, Mirabelli F, Giannone S, Laguardia M, Morviducci M BMC Infect Dis. 2024; 24(1):392.
PMID: 38605300 PMC: 11007928. DOI: 10.1186/s12879-024-09283-3.
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience.
Russo A, Serraino R, Serapide F, Bruni A, Garofalo E, Longhini F Heliyon. 2024; 10(2):e24298.
PMID: 38293516 PMC: 10825494. DOI: 10.1016/j.heliyon.2024.e24298.
Imaging Findings in Aspergillosis: From Head to Toe.
Sousa C, Pasini R, Pasqualotto A, Marchiori E, Altmayer S, Irion K Mycopathologia. 2023; 188(5):623-641.
PMID: 37380874 DOI: 10.1007/s11046-023-00766-6.